(Q81138571)

English

Adalimumab, a novel anti-tumor necrosis factor-alpha antibody in a child with refractory Crohn's disease

scientific article published on 01 September 2005

Statements

Adalimumab, a novel anti-tumor necrosis factor-alpha antibody in a child with refractory Crohn's disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit